Arthritis and Ozone Therapy: A Closer Look at the Joint, the Research, and the Results

Arthritis is one of the most prevalent chronic conditions affecting quality of life worldwide. It limits movement, generates persistent pain, and in more advanced forms significantly restricts daily function. Yet despite how common it is, the conventional approach — predominantly anti-inflammatory medications and pain management — addresses the symptoms far more than it addresses the underlying biology.

Ozone therapy offers something different. Supported by a growing body of international research, it engages with the cellular and biochemical environment of arthritic joints in a way that pharmaceutical intervention alone cannot.

Understanding Arthritis: Two Conditions, One Shared Mechanism

There are many forms of arthritis, but the two most prevalent and most studied in relation to ozone therapy are osteoarthritis (OA) and rheumatoid arthritis (RA). While these conditions differ significantly in origin, they share a critical common factor: chronic oxidative stress and immune dysregulation within the joint environment.

Osteoarthritis is primarily a degenerative condition. As joint cartilage breaks down over time through wear, injury, metabolic imbalance or ageing, the synovial environment becomes increasingly pro-inflammatory. Free radical activity accelerates cartilage degradation, microcirculation within the joint is compromised, and the body struggles to mount an effective repair response.

Rheumatoid arthritis is autoimmune in origin. The immune system attacks the synovial lining of joints, driving persistent inflammation, joint damage and elevated levels of pro-inflammatory cytokines; particularly TNF-α, IL-1 and IL-6. Left unresolved, this inflammatory cascade causes progressive structural deterioration.

Both conditions are characterised by elevated oxidative stress markers, depleted antioxidant defences, and a disrupted redox balance. This shared biology is precisely why ozone therapy has emerged as a meaningful complementary approach in both.

What Ozone Does Inside the Joint Environment

Ozone therapy works via a principle known as oxidative preconditioning: the introduction of a carefully controlled, low-dose oxidative stimulus that activates the body's own regulatory and repair mechanisms.

When medical ozone interacts with blood or biological tissue, it generates short-chain hydroxy-hydroperoxides from unsaturated fatty acids. These act as second messenger molecules, triggering a cascade of beneficial cellular responses:

• Activation of the Nrf2 pathway, which upregulates the body's antioxidant enzyme systems including superoxide dismutase (SOD), catalase (CAT) and reduced glutathione (GSH)

• Downregulation of NF-κB, a nuclear factor that drives pro-inflammatory cytokine production

• Reduction of TNF-α and IL-1β, the principal inflammatory drivers in rheumatoid arthritis

• Improved microcirculation to the joint, enhancing oxygen delivery to tissues that are frequently hypoxic in arthritic conditions

• Improved red blood cell flexibility and oxygen release, further supporting tissue oxygenation in areas of impaired circulation

• 
  

Rather than blocking inflammation artificially, ozone therapy signals the body to regulate it from within. This distinction has meaningful clinical implications, particularly for long-term joint health.

What the Research Shows

The volume and quality of research into ozone therapy for arthritis has grown steadily over the past decade. A 2024 double-blind randomised controlled trial demonstrated that ozone proved effective in reducing pain and improving functional mobility in patients with knee osteoarthritis, with benefits observed across the 3 to 6 month follow-up period.

In rheumatoid arthritis specifically, clinical research published in Pharmaceuticals in 2024 by León Fernández and colleagues — some of the most respected researchers in ozone pharmacology — demonstrated that ozone therapy combined with standard drug treatment produced significantly greater improvements in antioxidant defences, reductions in injury biomarkers, and meaningful decreases in pain and disability scores compared with standard treatment alone. This was observed in RA patients even after accounting for the naturally elevated oxidative stress seen in this group compared to OA.

An earlier controlled study involving 60 patients with RA found that 20 rectal ozone insufflations, applied alongside conventional methotrexate therapy, produced greater improvements in disease activity scores, pain scales and antioxidant capacity than methotrexate alone. An important secondary finding emerged from this study: ozone also reduced the liver toxicity associated with long-term methotrexate use.

These are not isolated findings. They reflect a consistent pattern: ozone therapy improves the biochemical environment that arthritis disrupts, and does so without the side effect profile of prolonged pharmaceutical use.

The Significance of Liver Protection in RA Treatment

This point deserves particular attention. Rheumatoid arthritis is commonly treated with disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, which carry well-established risks of liver toxicity over time. Ozone therapy, specifically rectal insufflation and drinking ozonated water (which is possible with an Ohen Model 5) plays a role not only in managing joint pathology but in reducing the toxic burden on the liver.

How Ozone Therapy Is Applied for Arthritis

At the clinical level, ozone therapy is applied to arthritic conditions through several routes.

Rectal insufflation with an Ohen Model 5 delivers ozone systemically. It is the method of choice for achieving whole-body anti-inflammatory and antioxidant effects, and is particularly valuable in rheumatoid arthritis where inflammation is systemic rather than localised.

Transcutaneous ozone therapy applies ozone gas directly to the joint area, providing localised benefit. This approach supports the specific joint environment, improving local oxygenation and reducing localised inflammatory activity. It is particularly practical for accessible joints such as the knee.

For those incorporating ozone into a broader wellness routine at home, topically applied ozonated products such as Ohen's Organic Ozonated Olive Oil offer a complementary approach. While this does not replace systemic ozone therapy, it provides a meaningful topical dimension that many users incorporate alongside their therapy sessions for ongoing joint support.

A Sustainable Path for Joint Health

Arthritis is a condition that does not resolve on its own, and the choices made over months and years shape the trajectory of joint health significantly. Ozone therapy, supported by a body of research that continues to grow in both volume and quality, provides a non-invasive way to engage with the core biological drivers of both osteoarthritis and rheumatoid arthritis.

Through improved oxygen delivery, antioxidant regulation, cytokine modulation and circulation support, ozone addresses the joint environment that arthritis degrades; and does so in alignment with the body's own regulatory intelligence.

If you are living with arthritis and exploring evidence-based complementary approaches, ozone therapy with Ohen Group offers a starting point grounded in both science and clinical experience.